HPV vaccine decision making in pediatric primary care: a semi-structured interview study

Cayce C Hughes, Amanda L Jones, Kristen A Feemster, Alexander G Fiks, Cayce C Hughes, Amanda L Jones, Kristen A Feemster, Alexander G Fiks

Abstract

Background: Despite national recommendations, as of 2009 human papillomavirus (HPV) vaccination rates were low with < 30% of adolescent girls fully vaccinated. Research on barriers to vaccination has focused separately on parents, adolescents, or clinicians and not on the decision making process among all participants at the point of care. By incorporating three distinct perspectives, we sought to generate hypotheses to inform interventions to increase vaccine receipt.

Methods: Between March and June, 2010, we conducted qualitative interviews with 20 adolescent-mother-clinician triads (60 individual interviews) directly after a preventive visit with the initial HPV vaccine due. Interviews followed a guide based on published HPV literature, involved 9 practices, and continued until saturation of the primary themes was achieved. Purposive sampling balanced adolescent ages and practice type (urban resident teaching versus non-teaching). Using a modified grounded theory approach, we analyzed data with NVivo8 software both within and across triads to generate primary themes.

Results: The study population was comprised of 20 mothers (12 Black, 9 < high school diploma), 20 adolescents (ten 11-12 years old), and 20 clinicians (16 female). Nine adolescents received the HPV vaccine at the visit, eight of whom were African American. Among the 11 not vaccinated, all either concurrently received or were already up-to-date on Tdap and MCV4. We did not observe systematic patterns of vaccine acceptance or refusal based on adolescent age or years of clinician experience. We identified 3 themes: (1) Parents delayed, rather than refused vaccination, and when they expressed reluctance, clinicians were hesitant to engage them in discussion. (2) Clinicians used one of two strategies to present the HPV vaccine, either presenting it as a routine vaccine with no additional information or presenting it as optional and highlighting risks and benefits. (3) Teens considered themselves passive participants in decision making, even when parents and clinicians reported including them in the process.

Conclusions: Programs to improve HPV vaccine delivery in primary care should focus on promoting effective parent-clinician communication. Research is needed to evaluate strategies to help clinicians engage reluctant parents and passive teens in discussion and measure the impact of distinct clinician decision making approaches on HPV vaccine delivery.

References

    1. US Department of Health and Human Services. Approval Letter - Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant. Rockville, MD: Food and Drug Administration; 2006.
    1. US Department of Health and Human Services. Approval Letter - Cervarix. Rockville, MD: Food and Drug Administration; 2009.
    1. Kovacic MB, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Morales J, Alfaro M, Burk RD. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res. 2006;66:10112–9. doi: 10.1158/0008-5472.CAN-06-1812.
    1. Dunne EF, Unger ER, Sternberg M, McQuillian G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813–9. doi: 10.1001/jama.297.8.813.
    1. Winer RL, Feng Q, Hughes JP, O'Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis. 2008;197:279–82. doi: 10.1086/524875.
    1. Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Lim C, Whittle L, Brener ND, Wechsler H. Youth Risk Behavior Surveillance - United States, 2009. MMWR Surveill Summ. 2010;59:1–142.
    1. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Wahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, Greenacre M. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14. doi: 10.1016/S0140-6736(09)61248-4.
    1. Koutsky LA. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915–27.
    1. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56:1–24.
    1. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2009. MMWR Morb Mortal Wkly Rep. 2010. pp. 1018–1023.
    1. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127:77–84. doi: 10.1542/peds.2010-0812.
    1. Fernandez ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2010;31:235–52. doi: 10.1146/annurev.publhealth.012809.103609.
    1. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45:107–14. doi: 10.1016/j.ypmed.2007.05.013.
    1. Cox DS, Cox AD, Sturm L, Zimet G. Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls. Health Psychol. 2010;29:29–39.
    1. Roberts ME, Gerrard M, Reimer R, Gibbons FX. Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics. 2010;125:982–989. doi: 10.1542/peds.2009-2888.
    1. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine. 2011;29:890–895. doi: 10.1016/j.vaccine.2009.12.063.
    1. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45:528–31. doi: 10.1016/j.jadohealth.2009.02.006.
    1. Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19:531–8. doi: 10.1016/j.annepidem.2009.03.011.
    1. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health. 2009;18:1679–86. doi: 10.1089/jwh.2008.1329.
    1. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008;111:1103–10. doi: 10.1097/AOG.0b013e31817051fa.
    1. Zimet GD, Perkins SM, Sturm LA, Perkins SM, Sturm LA, Blair RM, Juliar BE, Mays RM. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health. 2005;37:179–86. doi: 10.1016/j.jadohealth.2005.06.004.
    1. Feemster KA, Winters SE, Fiks AG, Kinsman S, Kahn JA. Pediatricians' intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. J Adolesc Health. 2008;43:408–11. doi: 10.1016/j.jadohealth.2008.06.012.
    1. Tissot AM, Zimet GD, Rosenthal SL, Bernstein DI, Wetzel C, Kahn JA. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health. 2007;41:119–25. doi: 10.1016/j.jadohealth.2007.05.007.
    1. Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health. 2005;37:502–10. doi: 10.1016/j.jadohealth.2005.07.014.
    1. Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, Markowitz LE, Dunne EF, Stokley S, Dickinson LM, Berman S, Kempe A. National survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118:2280–9. doi: 10.1542/peds.2006-1946.
    1. Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123:1439–45. doi: 10.1542/peds.2008-1536.
    1. American Academy of Pediatrics. Recommendations for preventive pediatric health care.
    1. Kelle U. In: The Sage Handbook of Grounded Theory. Bryant A, Charmaz K, editor. Los Angeles: Sage Publications; 2007. Different approaches in grounded theory; pp. 191–213.
    1. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69:475–480. doi: 10.1016/j.socscimed.2009.05.024.
    1. Rand CM, Shone LP, Albertin C, Aulinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161:252–9. doi: 10.1001/archpedi.161.3.252.
    1. Jaccard J, Dittus PJ, Gordon VV. Parent-adolescent congruency in reports of adolescent sexual behavior and in communications about sexual behavior. Child Dev. 1998;69:247–61.
    1. O'Donnell L, Stueve A, Duran R, Myint UA, Agronick G, San Doval A, Wilson-Simmons R. Parenting practices, parents' underestimation of daughters' risks, and alcohol and sexual behaviors of urban girls. J Adolesc Health. 2008;42:496–502. doi: 10.1016/j.jadohealth.2007.10.008.
    1. Brown EC, Little P, Leydon GM. Communication challenges of HPV vaccination. Fam Pract. 2010;27:224–229. doi: 10.1093/fampra/cmp087.
    1. Krupp K, Marlow LA, Kielmann K, Doddaiah N, Mysore S, Reingold AL, Madhivanan P. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. J Adolesc Health. 2010;46:379–384. doi: 10.1016/j.jadohealth.2009.10.001.
    1. Levinson W, Lesser C, Epstein R. Developing physician communication skills for patient-centered care. Health Aff. 2010;29:1310–8. doi: 10.1377/hlthaff.2009.0450.
    1. Accredidation Council of Graduate Medical Education. 2007 Common program requirements. 2010. Accessed on July 26.
    1. Rollnick S, Heather N. Negotiating behaviour change in medical settings: the development of brief motivational interviewing. J Ment Health. 1992;1:25–38. doi: 10.3109/09638239209034509.
    1. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango) Soc Sci Med. 1997;44:681–92. doi: 10.1016/S0277-9536(96)00221-3.
    1. Bartholome WG. Informed consent, parental permission, and assent in pediatric practice. Pediatrics. 1995;96:981–2.
    1. Hilton S, Smith E. "I thought cancer was one of those random things. I didn't know cancer could be caught...": Adolescent girls' understandings and experiences of the HPV programme in the UK. Vaccine. 2011. in press .
    1. Williams K, Forster A, Marlow L, Waller J. Attitudes towards human papillomavirus vaccination: a qualitative study of vaccinated and unvaccinated girls aged 17-18 years. J Fam Plann Reprodu Health Care. 2011;37:22–25. doi: 10.1136/jfprhc.2010.0017.
    1. Marlow LAV, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007;25:1945–52. doi: 10.1016/j.vaccine.2007.01.059.
    1. Kahn JA, Chiou V, Allen JD, Goodman E, Perlman SE, Emans SJ. Beliefs about papanicolaou smears and compliance with papanicolaou smear follow-up in adolescents. Arch Pediatr Adolesc Med. 1999;153:1046–54.
    1. Kirby D. The impact of schools and school programs upon adolescent sexual behavior. J Sex Res. 2002;39:27–33. doi: 10.1080/00224490209552116.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅